Brain Metastasis Therapeutics Market Share, Global Trends, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2016 Future Market Insights www.futuremarketinsights.com [email protected] Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our client. Research Capabilities Sector Coverage Customized Research Syndicated Research Investment Research Social Media Research Automotive and Transportation Electronics, Semiconductor, and ICT Retail and Consumer Products Industrial Automation and Equipment Customized Research Subscription Information Syndicated Research For detailed subscription information please contact Investment Research T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268 Social Media Research Hari. T (Sr. Manager - Global Business Development) Email: [email protected] Chemicals & Materials Food and Beverages Services and Utilities Energy, Mining, Oil, and Gas Report Description Report Description Brain metastasis is a type of cancer that usually occurs due to the spread of cancerous cells to brain. Thus, it is also known as metastatic brain tumor or secondary brain cancer, while in primary brain cancer the tumor occurs in the brain. Brain metastasis is common as compared to the primary brain cancer. Brain metastasis is a major complication of systemic cancer and is one of the major reasons causing morbidity and mortality in cancer patients. The common type of cancer that spread to the brain are breast cancer, lung cancer, melanoma, renal cell carcinoma and colon. The cancer may spread to any part of brain but it is commonly found in the brain cerebrum. Cerebellum and stem cells are rarely found to be affected by brain metastasis. Brain metastasis may be single tumor or multiple, although multiple brain metastasis is common. The symptoms associated with brain metastasis are edema, seizure and severe headache. Therefore the first line of treatment for brain metastasis is treating the symptoms. Brain Metastasis Therapeutics Market: Drivers & Restraints The global brain metastasis therapeutics market is driven by the increasing need of treatment for symptoms associated with brain metastasis. Also, the chemotherapeutic agents are known to be the primary tools for cancer treatment which are estimated to increase the overall brain metastasis therapeutic market. The increased prevalence of cancer that spread to the brain are also expected to drive the global metastasis therapeutics market. Though the market seems to be opportunistic in the forecast period there are some factors such as high cost of treatment and side effects associated with the chemotherapy are expected to restrain the growth of brain metastasis therapeutics market. Report Description Report Description Request free sample Report: http://www.futuremarketinsights.com/reports/sample/repgb-1360 Brain Metastasis Therapeutics Market: Segmentation Brain metastasis therapeutics market is segmented on the basis of treatment type, end user, and region. Based on treatment, the global brain metastasis therapeutics market is segmented into: • Radiation therapy • Chemotherapy • Targeted therapy • Anticonvulsants • Corticosteroids Based on end use, the global brain metastasis therapeutics market is segmented into the following: • Cancer Hospitals • Clinics • Cancer Research Centers Report Description Report Description Brain Metastasis Therapeutics Market: Overview Chemotherapeutic drugs segment would hold maximum market share in overall brain metastasis market owing to widespread availability of variety of chemotherapeutic agents for the brain metastasis cancer treatment. The first line of treatment for brain metastasis is the treatments of symptoms through anticonvulsants and corticosteroids thus the market for these segments are expected to grow at faster rate over the forecast period. According to the American Association of Neurological Surgeons (AANS), in U.S, every year approximately 170,000 new cases of brain metastasis are diagnosed due to which the global brain metastasis market is estimated grow during the forecast period. Request for TOC: http://www.futuremarketinsights.com/toc/rep-gb-1360 Brain Metastasis Therapeutics Market: Region-wise Outlook Depending on geographic regions, global brain metastasis therapeutics market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa. Geographically, North America represents the largest regional market for brain metastasis therapeutics owing to high incidence rate of cancer. North America is followed by Europe and APEJ in terms of the increasing incidence of cancer. In Asia Pacific and Latin America, the market is expected to grow due to increase in healthcare awareness, continuously improving economy leading to increased affordability and relatively less competition as compared to that of developed regions of North America and Europe. Report Description Report Description It is also expected that a large percentage of cases which go unnoticed in developing countries will be recognized with advancing diagnostics and lead to a better market opportunity for therapeutics in Asia pacific. Brain Metastasis Therapeutics Market: Key Players Some of the major companies operating in the development and marketing of brain metastasis drugs includes Bayer AG, Pfizer Inc., Sanofi, F. Hoffmann-La Roche Ltd., Eli Lilly & Company, Novartis AG, GlaxoSmithKline, Merck & Co., Inc., AstraZeneca and AngioChem Inc. Browse full report: http://www.futuremarketinsights.com/reports/brain-metastasistherapeutics-market Thank You! To know more about us, please visit our website: www.futuremarketinsights.com For sales queries or new topics email us on: [email protected] For other queries contact: Mr. Sudip Saha Future Market Insights: 616 Corporate Way, Suite 2-9018, Valley Cottage, NY 10989, United States T: +1-347-918-3531 | D: +1-845-579-5705
© Copyright 2024